Hypoxia-Inducible Factor-1-Dependent Repression of E-cadherin in von Hippel-Lindau Tumor Suppressor–Null Renal Cell Carcinoma Mediated by TCF3, ZFHX1A …

B Krishnamachary, D Zagzag, H Nagasawa, K Rainey… - Cancer research, 2006 - AACR
B Krishnamachary, D Zagzag, H Nagasawa, K Rainey, H Okuyama, JH Baek, GL Semenza
Cancer research, 2006AACR
A critical event in the pathogenesis of invasive and metastatic cancer is E-cadherin loss of
function. Renal clear cell carcinoma (RCC) is characterized by loss of function of the von
Hippel-Lindau tumor suppressor (VHL), which negatively regulates hypoxia-inducible factor-
1 (HIF-1). Loss of E-cadherin expression and decreased cell-cell adhesion in VHL-null
RCC4 cells were corrected by enforced expression of VHL, a dominant-negative HIF-1α
mutant, or a short hairpin RNA directed against HIF-1α. In human RCC biopsies, expression …
Abstract
A critical event in the pathogenesis of invasive and metastatic cancer is E-cadherin loss of function. Renal clear cell carcinoma (RCC) is characterized by loss of function of the von Hippel-Lindau tumor suppressor (VHL), which negatively regulates hypoxia-inducible factor-1 (HIF-1). Loss of E-cadherin expression and decreased cell-cell adhesion in VHL-null RCC4 cells were corrected by enforced expression of VHL, a dominant-negative HIF-1α mutant, or a short hairpin RNA directed against HIF-1α. In human RCC biopsies, expression of E-cadherin and HIF-1α was mutually exclusive. The expression of mRNAs encoding TCF3, ZFHX1A, and ZFHX1B, which repress E-cadherin gene transcription, was increased in VHL-null RCC4 cells in a HIF-1–dependent manner. Thus, HIF-1 contributes to the epithelial-mesenchymal transition in VHL-null RCC by indirect repression of E-cadherin. (Cancer Res 2006; 66(5): 2725-31)
AACR